Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial
Lan Wang(Hebei Medical University), Chun Han(Hebei Medical University), Shutang Liu(Hebei Medical University), Qi Wang(Hebei Medical University), Xiaoning Li(Wuhan University), Xiaoxi Chen(Hebei Medical University), Lihong Liu(Hebei Medical University), Jing Han(Hebei Medical University), Yu Cao(Kunming Medical University)
Cited by 6
Related Papers
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke
|JAMA|2023|209
Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke
|JAMA|2022|185
Stretchable Energy‐Harvesting Tactile Interactive Interface with Liquid‐Metal‐Nanoparticle‐Based Electrodes
|Advanced Functional Materials|2020|167
Cascaded metasurfaces for high-purity vortex generation
|Nature Communications|2023|117
P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer
|Biochemical and Biophysical Research Communications|2019|97